arginine has been researched along with phenprocoumon in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Blau, N; Guerrero, L; Hofer, S; Schaffner, A; Schneemann, M; Schoedon, G | 1 |
Brandslund, I; Dahler-Eriksen, BS; Larsen, TB; Lassen, JF; Petersen, PH | 1 |
Fenyvesi, T; Harenberg, J; Joerg, I | 1 |
Breddin, HK; Graff, J; Harder, S; Klinkhardt, U; Osakabe, M; von Hentig, N; Walenga, JM; Watanabe, H | 1 |
Breddin, HK; Drenth, AF; Harder, S; Hoppensteadt, DA; Mayuga, M; Osakabe, M; Prechel, M; Walenga, JM; Watanabe, H | 1 |
Greinacher, A; Heid, J; Katus, HA; Müller, OJ | 1 |
1 trial(s) available for arginine and phenprocoumon
Article | Year |
---|---|
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
Topics: Acenocoumarol; Administration, Oral; Adult; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Drug Monitoring; Drug Therapy, Combination; Endopeptidases; Humans; International Normalized Ratio; Male; Partial Thromboplastin Time; Phenprocoumon; Pipecolic Acids; Prothrombin Time; Regression Analysis; Statistical Distributions; Sulfonamides | 2004 |
6 other study(ies) available for arginine and phenprocoumon
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages.
Topics: Alcohol Oxidoreductases; Amino Acid Oxidoreductases; Animals; Arginine; Biopterins; Cells, Cultured; Cytosol; Dexamethasone; GTP Cyclohydrolase; Hypoxanthines; Macrophages; Mice; Mice, Inbred C3H; Nitric Oxide; Nitric Oxide Synthase; Phenprocoumon | 1993 |
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Case-Control Studies; Factor V; Female; Glycine; Humans; Immunoenzyme Techniques; Linear Models; Male; Middle Aged; Phenprocoumon; Point Mutation; Polymerase Chain Reaction; Statistics, Nonparametric; Warfarin | 1998 |
Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation.
Topics: Administration, Oral; Anticoagulants; Arginine; Azetidines; Benzylamines; Drug Synergism; Glycine; Hirudins; Humans; Phenprocoumon; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides | 2002 |
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.
Topics: Acenocoumarol; Administration, Oral; Adult; Anticoagulants; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Humans; Infusions, Intravenous; International Normalized Ratio; Male; Phenprocoumon; Pipecolic Acids; Sulfonamides; Thrombin; Vitamin K | 2008 |
Idiopathic catastrophic thrombosis with happy ending.
Topics: Anticoagulants; Antithrombins; Arginine; Awareness; Blood Coagulation Tests; Coronary Artery Bypass; Heparin; Humans; Male; Middle Aged; Phenprocoumon; Pipecolic Acids; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome; Ultrasonography; Venous Thrombosis | 2017 |